| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Cyclerion Therapeutics, Inc. | President and Chief Executive Officer, Director | Common Stock | 100,303 | $340,529 | $3.40 | 01 Jan 2024 | Direct |
| Cyclerion Therapeutics, Inc. | President and Chief Executive Officer, Director | Stock Option (Right to Buy) | 55,849 | 05 Aug 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CYCN | Cyclerion Therapeutics, Inc. | 05 Aug 2024 | 1 | $0 | 4 | President and Chief Executive Officer, Director | 07 Aug 2024, 16:05 |
| CYCN | Cyclerion Therapeutics, Inc. | 01 Jan 2024 | 1 | $0 | 4 | President | 26 Jan 2024, 16:05 |
| CYCN | Cyclerion Therapeutics, Inc. | 01 Dec 2023 | 0 | $0 | 3/A | President | 07 Dec 2023, 16:05 |